Assessment of the Memory Immune Response, Safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With a Single Dose of JE-CV and Long-Term Follow-Up [EXTENSION OF 700036896]

Trial Profile

Assessment of the Memory Immune Response, Safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With a Single Dose of JE-CV and Long-Term Follow-Up [EXTENSION OF 700036896]

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Jul 2016

At a glance

  • Drugs Japanese encephalitis vaccine (Primary) ; Varicella zoster virus vaccine live
  • Indications Chickenpox; Japanese encephalitis
  • Focus Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 05 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 01 Apr 2014 Planned End Date changed from 1 May 2016 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
    • 08 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top